Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.

about

Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.

Item

http://www.wikidata.org/entity/Q50026139

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Plasmatic estradiol concentrat ...... les of in vitro fertilization.

@en

Plasmatic estradiol concentrat ...... les of in vitro fertilization.

@nl

type

Item

label

Plasmatic estradiol concentrat ...... les of in vitro fertilization.

@en

Plasmatic estradiol concentrat ...... les of in vitro fertilization.

@nl

prefLabel

Plasmatic estradiol concentrat ...... les of in vitro fertilization.

@en

Plasmatic estradiol concentrat ...... les of in vitro fertilization.

@nl

P1476

Plasmatic estradiol concentrat ...... les of in vitro fertilization.

@en

P2093

Eduardo C Castro

http://www.w3.org/2001/XMLSchema#string

Marcos V da Cunha

http://www.w3.org/2001/XMLSchema#string

Marta C C F Finotti

http://www.w3.org/2001/XMLSchema#string

Melaynne S B Meira

http://www.w3.org/2001/XMLSchema#string

Mylena N C R Camarço

http://www.w3.org/2001/XMLSchema#string

Rodopiano S Florêncio

http://www.w3.org/2001/XMLSchema#string

Vinicius A de Oliveira

http://www.w3.org/2001/XMLSchema#string

P2860

Estrogen supplementation to progesterone as luteal phase support in patients undergoing in vitro fertilization: systematic review and meta-analysis

Estradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial.

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles - a randomized controlled study.

Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles.

The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis.

Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis.

Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF.

Luteal estradiol supplementation in gonadotropin-releasing hormone antagonist cycles for infertile patients in vitro fertilization.

Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting.

Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.

P304

8-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5935/1518-0557.20180005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29338136

http://www.w3.org/2001/XMLSchema#string

P932

5844653

http://www.w3.org/2001/XMLSchema#string